Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2021 1
2022 3
2023 3
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

6 results

Results by year

Filters applied: . Clear all
Page 1
Practical considerations for navigating the regulatory landscape of non-clinical studies for clinical translation of radiopharmaceuticals.
Korde A, Mikolajczak R, Kolenc P, Bouziotis P, Westin H, Lauritzen M, Koole M, Herth MM, Bardiès M, Martins AF, Paulo A, Lyashchenko SK, Todde S, Nag S, Lamprou E, Abrunhosa A, Giammarile F, Decristoforo C. Korde A, et al. Among authors: kolenc p. EJNMMI Radiopharm Chem. 2022 Jul 19;7(1):18. doi: 10.1186/s41181-022-00168-x. EJNMMI Radiopharm Chem. 2022. PMID: 35852679 Free PMC article. Review.
EANM guideline on quality risk management for radiopharmaceuticals.
Gillings N, Hjelstuen O, Behe M, Decristoforo C, Elsinga PH, Ferrari V, Kiss OC, Kolenc P, Koziorowski J, Laverman P, Mindt TL, Ocak M, Patt M, Todde S, Walte A. Gillings N, et al. Among authors: kolenc p. Eur J Nucl Med Mol Imaging. 2022 Aug;49(10):3353-3364. doi: 10.1007/s00259-022-05738-4. Epub 2022 Apr 7. Eur J Nucl Med Mol Imaging. 2022. PMID: 35385986 Free PMC article.
Comparison of 99mTc radiolabeled somatostatin antagonist with [68 Ga]Ga-DOTA-TATE in a patient with advanced neuroendocrine tumor.
Opalinska M, Lezaic L, Decristoforo C, Kolenc P, Mikolajczak R, Studen A, Simoncic U, Virgolini I, Trofimiuk-Muldner M, Garnuszek P, Rangger C, Fani M, Glowa B, Skorkiewicz K, Hubalewska-Dydejczyk A. Opalinska M, et al. Among authors: kolenc p. Eur J Nucl Med Mol Imaging. 2023 Nov;50(13):4110-4111. doi: 10.1007/s00259-023-06335-9. Epub 2023 Jul 15. Eur J Nucl Med Mol Imaging. 2023. PMID: 37452871 Free PMC article. No abstract available.
[111In]In-CP04 as a novel cholecystokinin-2 receptor ligand with theranostic potential in patients with progressive or metastatic medullary thyroid cancer: final results of a GRAN-T-MTC Phase I clinical trial.
Lezaic L, Erba PA, Decristoforo C, Zaletel K, Mikolajczak R, Maecke H, Maina T, Konijnenberg M, Kolenc P, Trofimiuk-Müldner M, Przybylik-Mazurek E, Virgolini I, de Jong M, Fröberg AC, Rangger C, Di Santo G, Skorkiewicz K, Garnuszek P, Solnica B, Nock BA, Fedak D, Gaweda P, Hubalewska-Dydejczyk A. Lezaic L, et al. Among authors: kolenc p. Eur J Nucl Med Mol Imaging. 2023 Feb;50(3):892-907. doi: 10.1007/s00259-022-05992-6. Epub 2022 Nov 5. Eur J Nucl Med Mol Imaging. 2023. PMID: 36334104 Free PMC article. Clinical Trial.